Literature DB >> 20041966

Disorders related with ageing in the gerbil female prostate (Skene's paraurethral glands).

Ana M G Custodio1, Fernanda C A Santos, Silvana G P Campos, Patricia Simone Leite Vilamaior, Sérgio M Oliveira, Rejane M Góes, Sebastião R Taboga.   

Abstract

The female organs, which are regulated by steroid hormones, are targets of studies especially those related to senescence. However, although the female prostate is an organ influenced by hormones and susceptible to lesions, there is still little information about its histopathology. Thus, given the morphophysiological similarity between the prostate in women and female gerbils, the present study aimed to identify the spontaneous histopathological changes in this rodent to provide contributions to the understanding of lesions that also affect the human female prostate. The structural, ultrastructural, immunohistochemical, morphometric-stereological and serological aspects, as well as the quantification of the incidence, multiplicity and percentage of acini affected by different lesions were analyzed. Benign prostate lesions including hyperplasia, prostatitis, microcalculi and calculi; preneoplastic lesions like dysplasias; premalignant lesions, such as high grade prostatic intraepithelial neoplasia as well as malignant ones, specifically adenocarcinoma, were identified in the adult gland, but they were intensified during senescence, which is possibly due to the imbalance among steroid hormone levels. Although clinical attention focuses on other urogenital organs, the real condition of the histopathological injuries in the human female prostate should be considered. A serious preventive work regarding the female prostate could be applied in the gynaecological context in order to monitor the gland and avoid possible disturbances to women's health and consequently provide better quality of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20041966      PMCID: PMC2965899          DOI: 10.1111/j.1365-2613.2009.00685.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  35 in total

1.  Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

Authors:  Joyce A O'Shaughnessy; Gary J Kelloff; Gary B Gordon; Andrew J Dannenberg; Waun Ki Hong; Carol J Fabian; Caroline C Sigman; Monica M Bertagnolli; Steven P Stratton; Stephen Lam; William G Nelson; Frank L Meyskens; David S Alberts; Michele Follen; Anil K Rustgi; Vali Papadimitrakopoulou; Peter T Scardino; Adi F Gazdar; Lee W Wattenberg; Michael B Sporn; Wael A Sakr; Scott M Lippman; Daniel D Von Hoff
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

2.  Structure, histochemistry, and ultrastructure of the epithelium and stroma in the gerbil (Meriones unguiculatus) female prostate.

Authors:  F C A dos Santos; H F Carvalho; R M Góes; S R Taboga
Journal:  Tissue Cell       Date:  2003-12       Impact factor: 2.466

Review 3.  AgNOR staining and quantification.

Authors:  D Trerè
Journal:  Micron       Date:  2000-04       Impact factor: 2.251

4.  Adenocarcinoma of female paraurethral duct showing neuroendocrine differentiation.

Authors:  A H Islam; H Kato; M Hayama; S Kobayashi; H Ota; O Nishizawa
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

5.  Androgen deficiency in women.

Authors:  K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

Review 6.  Oestrogens and prostate cancer.

Authors:  G P Risbridger; J J Bianco; S J Ellem; S J McPherson
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

7.  Antiestrogen therapies affect tissue homeostasis of the gerbil (Meriones unguiculatus) female prostate and ovaries.

Authors:  Fernanda C A Santos; Ana M G Custodio; Silvana G P Campos; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Biol Reprod       Date:  2008-05-21       Impact factor: 4.285

Review 8.  Hormones and prostate cancer: current perspectives and future directions.

Authors:  Ann W Hsing; Juergen K V Reichardt; Frank Z Stanczyk
Journal:  Prostate       Date:  2002-08-01       Impact factor: 4.104

Review 9.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

10.  The role of dihydrotestosterone in benign prostatic hyperplasia.

Authors:  Culley Carson; Roger Rittmaster
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

View more
  3 in total

1.  Exposure to ethinylestradiol during prenatal development and postnatal supplementation with testosterone causes morphophysiological alterations in the prostate of male and female adult gerbils.

Authors:  Ana Paula Silva Perez; Manoel Francisco Biancardi; Rejane Maira Góes; Fernanda Alcântara dos Santos; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

2.  Prenatal exposure to ethinylestradiol alters the morphologic patterns and increases the predisposition for prostatic lesions in male and female gerbils during ageing.

Authors:  Ana P S Perez; Manoel F Biancardi; Cássia R S Caires; Luiz R Falleiros-Junior; Rejane M Góes; Patricia S L Vilamaior; Fernanda C A Santos; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2016-02-08       Impact factor: 1.925

3.  Telocytes play a key role in prostate tissue organisation during the gland morphogenesis.

Authors:  Bruno D A Sanches; Juliana S Maldarine; Bruno C Zani; Guilherme H Tamarindo; Manoel F Biancardi; Fernanda C A Santos; Paula Rahal; Rejane M Góes; Sérgio L Felisbino; Patricia S L Vilamaior; Sebastião R Taboga
Journal:  J Cell Mol Med       Date:  2017-08-24       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.